Literature DB >> 3904445

Uveitis: many diseases, one diagnosis.

J T Rosenbaum, R A Nozik.   

Abstract

Entities:  

Mesh:

Year:  1985        PMID: 3904445     DOI: 10.1016/0002-9343(85)90049-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

Review 1.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Contrasting ocular effects of local versus systemic endotoxin.

Authors:  James T Rosenbaum; April Woods; Jelena Kezic; Stephen R Planck; Holly L Rosenzweig
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-17       Impact factor: 4.799

3.  T cell-antigen-presenting cell interactions visualized in vivo in a model of antigen-specific inflammation.

Authors:  James T Rosenbaum; Mischa B Ronick; Xubo Song; Dongseok Choi; Stephen R Planck
Journal:  Clin Immunol       Date:  2008-03       Impact factor: 3.969

Review 4.  Current approach in diagnosis and management of anterior uveitis.

Authors:  Rupesh V Agrawal; Somasheila Murthy; Virender Sangwan; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

5.  Similar chemotactic factor for monocytes predominates in different animal models of uveitis.

Authors:  J T Rosenbaum; B W Seymour; W Raymond; L Langlois; M Wu; L David
Journal:  Inflammation       Date:  1988-06       Impact factor: 4.092

6.  Bright light activates a trigeminal nociceptive pathway.

Authors:  Keiichiro Okamoto; Akimasa Tashiro; Zheng Chang; David A Bereiter
Journal:  Pain       Date:  2010-03-04       Impact factor: 7.926

7.  Hypoxia inducible factors are dispensable for myeloid cell migration into the inflamed mouse eye.

Authors:  Peter J Gardner; Sidath E Liyanage; Enrico Cristante; Robert D Sampson; Andrew D Dick; Robin R Ali; James W Bainbridge
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.